vs

Side-by-side financial comparison of MESOBLAST LTD (MESO) and MESABI TRUST (MSB). Click either name above to swap in a different company.

MESABI TRUST is the larger business by last-quarter revenue ($3.6M vs $1.9M, roughly 1.9× MESOBLAST LTD). MESABI TRUST runs the higher net margin — 77.1% vs -959.3%, a 1036.3% gap on every dollar of revenue. On growth, MESOBLAST LTD posted the faster year-over-year revenue change (-3.6% vs -95.5%).

Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004.

Mesabi Trust is a United States-based royalty trust that holds permanent royalty interests in iron ore mining properties located in Minnesota's Mesabi Range. It earns revenue primarily from royalty payments tied to the production and sale of iron ore products, with core earnings sourced from active mining partners operating on the land it holds interests in, catering to the global steel manufacturing market.

MESO vs MSB — Head-to-Head

Bigger by revenue
MSB
MSB
1.9× larger
MSB
$3.6M
$1.9M
MESO
Growing faster (revenue YoY)
MESO
MESO
+91.9% gap
MESO
-3.6%
-95.5%
MSB
Higher net margin
MSB
MSB
1036.3% more per $
MSB
77.1%
-959.3%
MESO

Income Statement — Q3 FY2023 vs Q3 FY2026

Metric
MESO
MESO
MSB
MSB
Revenue
$1.9M
$3.6M
Net Profit
$-18.6M
$2.8M
Gross Margin
77.1%
Operating Margin
Net Margin
-959.3%
77.1%
Revenue YoY
-3.6%
-95.5%
Net Profit YoY
12.7%
-96.5%
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MESO
MESO
MSB
MSB
Q4 25
$3.6M
Q3 25
$5.6M
Q2 25
$4.7M
Q1 25
$6.9M
Q4 24
$79.0M
Q3 24
$6.5M
Q2 24
$6.3M
Q1 24
$6.2M
Net Profit
MESO
MESO
MSB
MSB
Q4 25
$2.8M
Q3 25
$4.7M
Q2 25
$3.6M
Q1 25
$6.1M
Q4 24
$78.3M
Q3 24
$5.4M
Q2 24
$3.5M
Q1 24
$4.7M
Gross Margin
MESO
MESO
MSB
MSB
Q4 25
77.1%
Q3 25
84.6%
Q2 25
76.7%
Q1 25
88.5%
Q4 24
99.1%
Q3 24
83.2%
Q2 24
55.7%
Q1 24
75.3%
Net Margin
MESO
MESO
MSB
MSB
Q4 25
77.1%
Q3 25
84.6%
Q2 25
76.7%
Q1 25
88.5%
Q4 24
99.1%
Q3 24
83.2%
Q2 24
55.7%
Q1 24
75.3%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MESO
MESO
MSB
MSB
Cash + ST InvestmentsLiquidity on hand
$48.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$482.2M
$21.1M
Total Assets
$650.4M
$26.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Stockholders' Equity
MESO
MESO
MSB
MSB
Q4 25
$21.1M
Q3 25
$22.8M
Q2 25
$19.6M
Q1 25
$23.3M
Q4 24
$95.3M
Q3 24
$22.1M
Q2 24
$20.7M
Q1 24
$21.0M
Total Assets
MESO
MESO
MSB
MSB
Q4 25
$26.0M
Q3 25
$24.8M
Q2 25
$27.4M
Q1 25
$101.7M
Q4 24
$100.7M
Q3 24
$26.2M
Q2 24
$25.1M
Q1 24
$26.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MESO
MESO
MSB
MSB
Operating Cash FlowLast quarter
$-16.3M
$3.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MESO
MESO
MSB
MSB
Q4 25
$3.5M
Q3 25
$4.4M
Q2 25
$2.1M
Q1 25
$93.9M
Q4 24
$78.2M
Q3 24
$3.8M
Q2 24
$2.5M
Q1 24
$14.6M
Cash Conversion
MESO
MESO
MSB
MSB
Q4 25
1.27×
Q3 25
0.92×
Q2 25
0.57×
Q1 25
15.48×
Q4 24
1.00×
Q3 24
0.71×
Q2 24
0.72×
Q1 24
3.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons